Related Experiment Video
Updated: Aug 7, 2026
09:03
Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
Published on: November 23, 2014
Mathematical modeling of tumor-induced angiogenesis
M A J Chaplain1, S R McDougall, A R A Anderson
1The SIMBIOS Center, Division of Mathematics, University of Dundee, Dundee DD1 4HN, Scotland. chaplain@maths.dundee.ac.uk
Annual Review of Biomedical Engineering
|July 13, 2006
Summary
Angiogenesis, the growth of blood vessels, fuels solid tumor expansion. Recent flow models offer new insights into anti-cancer therapies targeting tumor vascularization.
Area of Science:
- Oncology
- Biomedical Engineering
- Physiology
Background:
- Angiogenesis, the formation of new blood vessels, is essential for solid tumor growth, transitioning tumors from avascular to vascular states.
- This process involves complex endothelial cell behaviors, tissue remodeling, and network formation, ultimately enabling blood flow.
- Tumor vascular growth is a dynamic and adaptive process influenced by angiogenic factors, extracellular matrix cues, and hemodynamic forces.
Purpose of the Study:
- To review existing theoretical and computational models of angiogenesis.
- To explore how recent advancements in flow modeling can illuminate anti-cancer drug treatments.
Main Methods:
- Review of theoretical and computational models of angiogenesis.
- Analysis of recent developments in fluid dynamics models applied to tumor growth.
Main Results:
- Previous models have provided a foundation for understanding angiogenesis.
- Current flow models offer dynamic insights into tumor vascularization and its response to stimuli.
Conclusions:
- Understanding the dynamics of angiogenesis is critical for effective cancer treatment.
- Advanced flow models show promise in guiding the development of antiangiogenic and chemotherapeutic strategies.
Related Concept Videos
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...